Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01772472
Brief Title: A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)

First Submitted : January 17, 2013
First Submitted that Met QC Criteria : January 17, 2013
First Posted : January 21, 2013 (Estimate)

Results First Submitted : July 24, 2019
Results First Submitted that Met QC Criteria : September 9, 2019
Results First Posted : October 1, 2019

Last Update Submitted that Met QC Criteria : September 29, 2021
Last Update Posted : October 4, 2021